Devyser Q3 sales rise on portfolio expansion
Overview
Sweden diagnostics kit maker's Q3 net sales rose 5.8% yr/yr despite distributor inventory drag
Adjusted EPS for Q3 improved to SEK 0.43 from a loss last year
Company broadened product portfolio and signed new agreements to support future growth
Outlook
Company expects distributor inventory adjustment to continue impacting sales in Q4 2026
Devyser anticipates sales to the distributor will gradually normalize from 2027
Company sees underlying demand as strong despite near-term sales headwinds
Result Drivers
DISTRIBUTOR INVENTORY - Co said sales growth was held back by continued inventory adjustment at its largest distributor
PRODUCT PORTFOLIO EXPANSION - Co launched new chimerism assay with Thermo Fisher and broadened product portfolio
REAGENT RENTAL AGREEMENT - Co signed first reagent rental agreement in collaboration with Illumina to expand access to NGS
Company press release:
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Sales | SEK 59.70 mln | ||
Q3 Adjusted EPS | SEK 0.43 | ||
Q3 Adjusted Free Cash Flow | SEK 22 mln | ||
Q3 EBIT | SEK 7.10 mln |
Analyst Coverage
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the biotechnology & medical research peer group is "buy."
Wall Street's median 12-month price target for Devyser Diagnostics AB is SEK137.50, about 123.6% above its November 2 closing price of SEK61.50
The stock recently traded at 36 times the next 12-month earnings vs. a P/E of 48 three months ago
Reuters Recommended Reads
Nov 3 - Sweden's OssDsign Q3 net sales fall 5.4%, as expected
Nov 2 - Immunovia Q3 net sales surge on PancreaSure uptake
Nov 2 - Denmark medical devices maker Coloplast's Q4 revenue rises
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)